Fibrinaloid microclots in long COVID: assessing the actual evidence properly
Douglas B. Kell,
M. Asad Khan,
Etheresia Pretorius
Affiliations
Douglas B. Kell
Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK; The Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark; Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Matieland, South Africa
M. Asad Khan
Directorate of Respiratory Medicine, Manchester University Hospitals, Wythenshawe Hospital, Manchester, UK
Etheresia Pretorius
Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK; Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Matieland, South Africa; Correspondence Etheresia Pretorius, Stellenbosch University Faculty of Science, Physiological Sciences, Room 2052, Mike de Vries Building, Faculty of Science, Stellenbosch 7600, South Africa.
